secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2024-01-16T23:59:59+00:00
Accession:  0001437749-24-001348
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics raises ~$4.0M in registered direct offering of 2.97M shares at $1.55/share
--------------------------------------------------------------------------------

- Sold 2,967,742 common shares at $1.55 each; net proceeds ~$4.0M after fees and expenses.
- Offering closed on January 16, 2024; proceeds for general corporate purposes (R&D, SG&A, working capital).
- Exercise price of May 2019 warrants (193,060 outstanding) reduced from $3.52 to $1.55 per share due to anti-dilution.
- A.G.P./Alliance Global Partners acted as exclusive placement agent; fee of 7% of gross proceeds plus expense reimbursements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000143774924001348/0001437749-24-001348-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000143774924001348/ekso20240111_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-001348

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer